Designing the next-generation clinical care pathway for Alzheimer’s disease
Harald Hampel(Eisai (United States)), Jeffrey L. Cummings(University of Nevada, Las Vegas)
Cited by 193
Related Papers
The Amyloid-β Pathway in Alzheimer’s Disease
|Molecular Psychiatry|2021|1.8k
The β-Secretase BACE1 in Alzheimer’s Disease
|Biological Psychiatry|2020|657
Alzheimer's disease drug development pipeline: 2023
|Alzheimer s & Dementia Translational Research & Clinical Interventions|2023|457
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
|Neuron|2023|235
Burden of Illness in People with Alzheimer's Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
|The Journal of Prevention of Alzheimer s Disease|2023|139